Microba Life Sciences Ltd: Amended Constitution
Microba Life Sciences Ltd: Results of Annual General Meeting
Microba Life Sciences Ltd: 2024 Annual General Meeting Presentation
Microba Life Sciences Ltd: Bell Potter Healthcare Conference Presentation
Microba Life Sciences Ltd: Q1 FY25 Quarterly Activities Report & Appendix 4C
Microba Life Sciences Ltd: Q1 FY25 Quarterly Investor Presentation
Microba Life Sciences Ltd: Letter to Shareholders, Notice of AGM & Proxy Form
Microba Life Sciences Ltd: Date of AGM and Closing Date for Director Nominations
Microba Life Sciences Ltd: Microba Presents at ASX Small & Mid Cap Conference
Microba Life Sciences Ltd: Change of Joint Company Secretary Role
Microba Life Sciences Ltd: Q4 FY24 Quarterly Investor Presentation & Webinar
Microba Life Sciences Ltd: Microba Diagnostics Business Update to Bioshares Summit
Microba Life Sciences Ltd: Q3 FY24 Quarterly Investor Presentation
Microba Life Sciences Ltd: MetaPanel Launch Investor Presentation
Microba Life Sciences Ltd: Results of Annual General Meeting
Microba Life Sciences Ltd: 2023 AGM Presentations
Microba Life Sciences Ltd: Autoimmune Stage 1 Screening Complete with Gingko Bioworks
Microba Life Sciences Ltd: MAP CEO presents at Bell Potter Healthcare Conference 2023
Microba Life Sciences Ltd: Investor Presentation
Microba Life Sciences Ltd: Letter to Shareholders, Notice of AGM & Proxy Form
No Data